Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study-Reference-Cited by-同舟云学术

Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study

Published:2004-05 Issue:9421 Volume:363 Page:1598-1605
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Barnes KI,Mwenechanya J,Tembo M,Mcllleron H,Folb PI,Ribeiro I,Little F,Gomes M,Molyneux ME

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial;Kidane;Lancet,2000

2. Antimalarial drug resistance and mortality in falciparum malaria;White;Trop Med Int Health,1999

3. The pathophysiology of malaria;White;Adv Parasitol,1992

4. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives;White;Trans R Soc Trop Med Hyg,1994

5. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model;Janse;Int J Parasitol,1994

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the next generation of severe malaria treatment: a target product profile;Malaria Journal;2024-06-05

2. Fortschritte in der pharmakologischen Forschung an Artemisinin zur Malariabehandlung;Von Artemisia annua L. zu Artemisininen;2024

3. WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria;Transactions of The Royal Society of Tropical Medicine and Hygiene;2023-02-01

4. Guardians and research staff experiences and views about the consent process in hospital-based paediatric research studies in urban Malawi: A qualitative study;BMC Medical Ethics;2022-12-05

5. The wrongful indictment of pre-referral rectal artesunate further delays the roll-out of this lifesaving drug;The Lancet Infectious Diseases;2022-12